EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of ceramide synthase 5 inhibits the development of experimentally induced aortic valve stenosis

Laurine Reese iD, Sven Thomas Niepmann, Philip Düsing, Lea Hänschke iD, Thomas Beiert, Sebastian Zimmer, Georg Nickenig, Reinhard Bauer, Felix Jansen, Andreas Zietzer iD

Acta Physiologica · 2024-05 · 240 (5)

DOI: 10.1111/apha.14140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 28.03.2024. Verfasst von Laurine Reese und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Hospital Bonn, University of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Sphingosine N-Acyltransferase, Aortic Valve. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bonn, German Cardiac Society, Ernst & Berta Grimmke Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Inflammation and calcification are hallmarks in the development of aortic valve stenosis (AVS). Ceramides mediate inflammation and calcification in the vascular tissue. The highly abundant d18:1,16:0 ceramide (C16) has been linked to increased cardiovascular mortality and obesity. In this study, we investigate the role of ceramide synthase 5 (CerS5), a critical enzyme for C16 ceramide synthesis, in the development of AVS, particularly in conjunction with a high‐fat/high‐cholesterol diet (Western diet, WD).

Methods

We used wild‐type (WT) and CerS5 −/− mice on WD or normal chow in a wire injury model. We measured the peak velocity to determine AVS development and performed histological analysis of the aortic valve area, immune cell infiltration (CD68 staining), and calcification ( von Kossa ). In vitro experiments involved measuring the calcification of human aortic valvular interstitial cells (VICs) and evaluating cytokine release from THP‐1 cells, a human leukemia monocytic‐like cell line, following CerS5 knockdown.

Results

CerS5 −/− mice showed a reduced peak velocity compared to WT only in the experiment with WD. Likewise, we observed reduced immune cell infiltration and calcification in the aortic valve of CerS5 −/− mice, but only on WD. In vitro, calcification was reduced after knockdown of CerS5 in VICs, while THP‐1 cells exhibited a decreased inflammatory response following CerS5 knockdown.

Conclusion

We conclude that CerS5 is an important mediator for the development of AVS in mice on WD and regulates critical pathophysiological hallmarks of AVS formation. CerS5 is therefore an interesting target for pharmacological therapy and merits further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisSphingosine N-AcyltransferaseAortic ValveAnimalsMiceHumansMice, KnockoutMaleMice, Inbred C57BLDisease Models, AnimalCalcinosisTHP-1 Cells

Stichwörter der Autor:innen

aortic valve stenosiscalcificationceramideceramide synthase 5high fat/high cholesterol dietinflammation

Substanzen

Sphingosine N-Acyltransferase

Autor:innen und Institutionen

  • Department of Internal Medicine II, University Hospital Bonn, University of Bonn, Bonn, Germany.
  • Life & Medical Sciences Institute (LIMES), Genetics & Molecular Physiology, University of Bonn, Bonn, Germany.

ORCID-Profile: Laurine Reese, Lea Hänschke, Andreas Zietzer

Förderung

  • University of Bonn
  • German Cardiac Society
  • Ernst & Berta Grimmke Foundation
  • Deutsche Forschungsgemeinschaft
  • Corona-Foundation
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.

Zitieren

APA

Reese, L., Niepmann, S. T., Düsing, P., Hänschke, L., Beiert, T., Zimmer, S., Nickenig, G., Bauer, R., Jansen, F., & Zietzer, A. (2024). Loss of ceramide synthase 5 inhibits the development of experimentally induced aortic valve stenosis. Acta Physiologica, 240(5). https://doi.org/10.1111/apha.14140

Vancouver

Reese L, Niepmann ST, Düsing P, Hänschke L, Beiert T, Zimmer S, et al. Loss of ceramide synthase 5 inhibits the development of experimentally induced aortic valve stenosis. Acta Physiologica. 2024;240(5). doi:10.1111/apha.14140

BibTeX
@article{Reese2024,
  author = {Reese, Laurine and Niepmann, Sven Thomas and Düsing, Philip and Hänschke, Lea and Beiert, Thomas and Zimmer, Sebastian and Nickenig, Georg and Bauer, Reinhard and Jansen, Felix and Zietzer, Andreas},
  title = {Loss of ceramide synthase 5 inhibits the development of experimentally induced aortic valve stenosis},
  journal = {Acta Physiologica},
  year = {2024},
  volume = {240},
  number = {5},
  doi = {10.1111/apha.14140}
}
Kostenlos starten →